Speakers
|
Sameer Awsare |
Kaiser Permanente, The Permanente Medical Group, Associate Executive Director Sameer.Awsare@kp.org |
|
Dora Hughes |
Sidley Austin, LLP, Senior Policy Advisor dhughes@sidley.com |
|
Robert Langreth |
Bloomberg News, Senior Health Reporter rlangreth@bloomberg.net |
Experts and Analysts
|
Peter Bach |
Memorial Sloan Kettering Cancer Center, Center of Health Policy and Outcomes, Director 646/888-8217 bachp@mskcc.org |
|
Sean Cavanaugh |
Aledade, Chief Administrative Officer sean@aledade.com |
|
James Czaban |
DLA Piper LLP, FDA Practice Group, Chair 202/799-4045 james.czaban@dlapiper.com |
|
Benjamin Isgur |
PricewaterhouseCoopers LLP, Health Research Institute, Leader 214/754-5091 benjamin.isgur@pwc.com |
|
Andrew Mulcahy |
RAND Corporation, Economics, Sociology, and Statistics Department, Associate Director 703/413-1100 amulcahy@rand.org |
|
Trish Riley |
National Academy for State Health Policy, Executive Director triley@nashp.org |
|
Gillian Woollett |
Avalere Health LLC, FDA Practice, Senior Vice President 202/207-1300 gwoollett@avalere.com |
Government
|
Jessica Banthin |
Congressional Budget Office, Health, Retirement, and Long-Term Analysis Division, Deputy Assistant Director 202/226-2602 |
|
Cliff Binder |
Congressional Research Service, Health Insurance and 202/227-7965 cbinder@crs.loc.gov |
|
Leah Christl |
U.S. Food and Drug Administration, Center for Drug Evaluation 301/796-0869 |
|
Anne Schwartz |
Medicaid and CHIP Payment and Access Commission, Executive Director 202/350-2000 anne.schwartz@macpac.gov |
Stakeholders
|
Craig Burns |
America’s Health Insurance Plans, Vice President of Research 202/778-8503 cburns@ahip.org |
|
Andrew Dreyfus |
Blue Cross Blue Shield of Massachusetts, President and CEO 617/246-3800 andrew.dreyfus@bcbsma.com |
|
Eleanor Perfetto |
National Health Council, Strategic Initiatives, Senior Vice President 215/785-3910 eperfetto@nhcouncil.org |
|
Leigh Purvis |
AARP Public Policy Institute, Health Services Research, Director 202/360-1681 lpurvis@aarp.org |
|
Lori Reilly |
Pharmaceutical Research and Manufacturers of America Policy, Research & Membership, Executive Vice President 202/835-3400 LReilly@phrma.org |
|
Michael Reilly |
Alliance for Safe Biologic Medicines, Executive Director 202/222-8326 michael@safebiologics.org |